Notably, the negative correlations of four key markers, UBE2T, TEDC2, RCC1, and FAM136A, with stromal, immune, and ESTIMATE scores suggest that the high expression of these genes in LUAD may contribute to tumor growth and malignant behaviors by inhibiting the role of stromal and immune cells. The gene discussed is RCC1; the disease is neoplasm.